VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > How much could be a buyout?

<< Previous

Bullboard Posts

Next >>

Comment by bluemoons20on Dec 17, 2021 8:58am

126 Views

Post# 34239964

RE:How much could be a buyout?

Excellent question.. In the past year there have been guesses on the board of from $4 to $ 10 per share. (These however were before the financing which doubled the number of shares.)

Probably around $5 would get you to 1B fully diluted

I am not sure but maybe if we asked George to do another financing and have more shares out , the value could go up to 2B ??

Sounds like a good time to wish everyone the best of the New Year and Happy Hollidays!

GLTA

<< Previous

Bullboard Posts

Next >>

Ur-Energy revises uranium production guidance for 2024